• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物代谢中体外筛选的应用策略。

Strategies for using in vitro screens in drug metabolism.

作者信息

Plant Nick

机构信息

School of Biomedical and Molecular Sciences, University of Surrey, Guildford, UK.

出版信息

Drug Discov Today. 2004 Apr 1;9(7):328-36. doi: 10.1016/s1359-6446(03)03019-8.

DOI:10.1016/s1359-6446(03)03019-8
PMID:15053006
Abstract

In vitro assays are increasingly being used in drug metabolism studies to screen novel chemicals. Their advantages are twofold: first, they allow testing early in the drug discovery phase, providing important information on chemical characteristics; second, human cells or cell constituents can be utilized, increasing the relevance to man. However, the process of isolation, transformation or storage of these cell systems may alter their phenotype (and, in the case of tumour-derived cell lines, genotype as well). A review of the systems currently employed shows that, whereas all systems have their own caveats, it is possible to find an appropriate system for any particular question that is asked.

摘要

体外试验在药物代谢研究中越来越多地用于筛选新型化学品。其优点有两方面:其一,它们允许在药物发现阶段早期进行测试,提供有关化学特性的重要信息;其二,可以利用人类细胞或细胞成分,提高与人体的相关性。然而,这些细胞系统的分离、转化或储存过程可能会改变其表型(对于肿瘤衍生细胞系,还会改变基因型)。对目前使用的系统进行的综述表明,虽然所有系统都有其自身的注意事项,但针对所提出的任何特定问题都有可能找到合适的系统。

相似文献

1
Strategies for using in vitro screens in drug metabolism.药物代谢中体外筛选的应用策略。
Drug Discov Today. 2004 Apr 1;9(7):328-36. doi: 10.1016/s1359-6446(03)03019-8.
2
Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.药物研发中的代谢谱分析以及细胞色素P450抑制与诱导作用
Curr Top Med Chem. 2001 Nov;1(5):403-25. doi: 10.2174/1568026013395001.
3
[Application and development of in vitro metabolism study at early drug discovery stage].[体外代谢研究在药物发现早期阶段的应用与发展]
Yao Xue Xue Bao. 2013 Jul;48(7):1071-9.
4
The application of in vitro models of drug metabolism and toxicity in drug discovery and drug development.药物代谢与毒性的体外模型在药物发现和药物开发中的应用。
Drug Chem Toxicol. 1995 Feb;18(1):1-28. doi: 10.3109/01480549509017855.
5
Biohybrid Membrane Systems and Bioreactors as Tools for In Vitro Drug Testing.生物杂交膜系统和生物反应器作为体外药物测试工具
Curr Pharm Des. 2017;23(2):319-327. doi: 10.2174/1381612822666161025155616.
6
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.用于研究人类肝脏药物代谢和酶诱导作用的细胞模型。
Expert Opin Drug Metab Toxicol. 2005 Jun;1(1):75-90. doi: 10.1517/17425255.1.1.75.
7
In vitro screening of drug metabolism during drug development: can we trust the predictions?药物研发过程中药物代谢的体外筛选:我们能相信这些预测吗?
Expert Opin Drug Metab Toxicol. 2005 Jun;1(1):49-59. doi: 10.1517/17425255.1.1.49.
8
High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.用于研究药物代谢和药代动力学的高通量筛选方法。
Xenobiotica. 2001 Aug-Sep;31(8-9):557-89. doi: 10.1080/00498250110060978.
9
Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.药物发现与开发中的代谢稳定性:药代动力学和生物化学挑战。
Clin Pharmacokinet. 2003;42(6):515-28. doi: 10.2165/00003088-200342060-00002.
10
High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.药物代谢与药代动力学中的高通量筛选对药物发现的支持。
Annu Rev Pharmacol Toxicol. 2000;40:133-57. doi: 10.1146/annurev.pharmtox.40.1.133.

引用本文的文献

1
Hepa-ToxMOA: a pathway-screening method for evaluating cellular stress and hepatic metabolic-dependent toxicity of natural products.Hepa-ToxMOA:一种用于评估天然产物细胞应激和肝代谢依赖性毒性的途径筛选方法。
Sci Rep. 2024 Feb 21;14(1):4319. doi: 10.1038/s41598-024-54634-4.
2
Molecular chameleons in drug discovery.药物发现中的分子变色龙。
Nat Rev Chem. 2024 Jan;8(1):45-60. doi: 10.1038/s41570-023-00563-1. Epub 2023 Dec 20.
3
One-Step Regio- and Stereoselective Electrochemical Synthesis of Orexin Receptor Antagonist Oxidative Metabolites.
食欲素受体拮抗剂氧化代谢物的一步区域和立体选择性电化学合成
J Org Chem. 2022 Nov 18;87(22):15011-15021. doi: 10.1021/acs.joc.2c01311. Epub 2022 Nov 2.
4
Design and Synthesis of ()-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights.()-5-(取代亚苄基)-3-环己基-2-硫代噻唑烷-4-酮类似物作为抗酪氨酸酶和抗氧化化合物的设计与合成:体外和计算机模拟研究
Antioxidants (Basel). 2022 Sep 27;11(10):1918. doi: 10.3390/antiox11101918.
5
A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma.一种简单的 LC-MS/MS 法测定人血浆中 PDA-66 的浓度。
Molecules. 2022 Feb 1;27(3):974. doi: 10.3390/molecules27030974.
6
Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With Activity and Favorable Pharmacokinetics.具有活性和良好药代动力学的锥虫克鲁兹蛋白酶抑制剂的多参数优化
Front Pharmacol. 2022 Jan 5;12:774069. doi: 10.3389/fphar.2021.774069. eCollection 2021.
7
Determination of the Absolute Configuration of Bioactive Indole-Containing Pyrazino[2,1-]quinazoline-3,6-diones and Study of Their Metabolic Profile.测定具有生物活性的含吲哚吡嗪并[2,1-]喹唑啉-3,6-二酮的绝对构型及研究其代谢特征。
Molecules. 2021 Aug 21;26(16):5070. doi: 10.3390/molecules26165070.
8
Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions.导致草药-药物相互作用产生矛盾结果的多方面因素。
Pharmaceutics. 2020 Dec 30;13(1):43. doi: 10.3390/pharmaceutics13010043.
9
A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'--Methylguanosine for the Treatment of Dengue Virus Infection.一种用于治疗登革热病毒感染的 2'-脱氧-2'-氟-2'-甲基鸟苷环状磷酰胺前药。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.00654-20.
10
In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula).应用猫、犬和普通帚尾袋貂(Trichosurus vulpecula)微粒体进行甲氟喹的体外肝脏代谢研究。
PLoS One. 2020 Apr 14;15(4):e0230975. doi: 10.1371/journal.pone.0230975. eCollection 2020.